We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Teligent Opens Product Development Lab in Estonia
News

Teligent Opens Product Development Lab in Estonia

Teligent Opens Product Development Lab in Estonia
News

Teligent Opens Product Development Lab in Estonia

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Teligent Opens Product Development Lab in Estonia"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Teligent Inc has announced that it has opened a pharmaceutical Product Development laboratory in Estonia. The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company's North American markets.

The 3,000-square foot facility also includes administrative space for quality assurance and supply chain employees who oversee the company's third-party contract manufacturing activities around the world.

"We are excited to strengthen our R&D capabilities through the opening of this product development lab in Estonia," commented Jason Grenfell-Gardner, President and CEO of the Company. "We are impressed by the caliber of scientific talent available in the country, and look forward to this lab working closely with our R&D colleagues in New Jersey.''

The Company established its operation in Estonia in 2015, where it has been managing logistics and supply relationships between third-party suppliers and the US and Canadian markets. Grenfell-Gardner concluded, ''The opening of this lab for analytical method and formulation work is the next step in our journey to build pharmaceutical capabilities in our Estonia business.''

Advertisement